115 related articles for article (PubMed ID: 37160693)
1. Molecular dynamics simulations reveal phosphorylation-induced conformational dynamics of the fibroblast growth factor receptor 1 kinase.
Mahapatra S; Jonniya NA; Koirala S; Kar P
J Biomol Struct Dyn; 2024 Apr; 42(6):2929-2941. PubMed ID: 37160693
[TBL] [Abstract][Full Text] [Related]
2. Dynamic conformational states of apo, ATP and cabozantinib bound TAM kinases to differentiate active-inactive kinetic models.
Naresh GKRS; Guruprasad L
J Biomol Struct Dyn; 2023; 41(21):11394-11414. PubMed ID: 36591700
[TBL] [Abstract][Full Text] [Related]
3. New insights into the structural dynamics of the kinase JNK3.
Mishra P; Günther S
Sci Rep; 2018 Jun; 8(1):9435. PubMed ID: 29930333
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 5 (FGF5) and its missense mutant FGF5-H174 underlying trichomegaly: a molecular dynamics simulation investigation.
Hoang SH
J Biomol Struct Dyn; 2023; 41(24):14786-14796. PubMed ID: 36905676
[TBL] [Abstract][Full Text] [Related]
5. Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells.
Wang C; Ke Y; Liu S; Pan S; Liu Z; Zhang H; Fan Z; Zhou C; Liu J; Wang F
J Biol Chem; 2018 Sep; 293(38):14839-14849. PubMed ID: 30093411
[TBL] [Abstract][Full Text] [Related]
6. Critical role of FLRT1 phosphorylation in the interdependent regulation of FLRT1 function and FGF receptor signalling.
Wheldon LM; Haines BP; Rajappa R; Mason I; Rigby PW; Heath JK
PLoS One; 2010 Apr; 5(4):e10264. PubMed ID: 20421966
[TBL] [Abstract][Full Text] [Related]
7. Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer.
Wu J; Wei T; Tang Q; Weng B; Li W; Jiang X; Ding T; Li X; Liang G; Cai Y; Ji J
BMC Cancer; 2015 Apr; 15():276. PubMed ID: 25880284
[TBL] [Abstract][Full Text] [Related]
8. Structural and dynamic insights into the energetics of activation loop rearrangement in FGFR1 kinase.
Klein T; Vajpai N; Phillips JJ; Davies G; Holdgate GA; Phillips C; Tucker JA; Norman RA; Scott AD; Higazi DR; Lowe D; Thompson GS; Breeze AL
Nat Commun; 2015 Jul; 6():7877. PubMed ID: 26203596
[TBL] [Abstract][Full Text] [Related]
9. Association of fibroblast growth factor receptor 1 with the adaptor protein Grb14. Characterization of a new receptor binding partner.
Reilly JF; Mickey G; Maher PA
J Biol Chem; 2000 Mar; 275(11):7771-8. PubMed ID: 10713090
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells.
Ronca R; Gualandi L; Crescini E; Calza S; Presta M; Dell'Era P
J Cell Mol Med; 2009 Aug; 13(8A):1489-98. PubMed ID: 19549074
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of structural and conformational properties of WNK kinase isoforms bound to an inhibitor: insights from molecular dynamic simulations.
Jonniya NA; Sk MF; Kar P
J Biomol Struct Dyn; 2022 Feb; 40(3):1400-1415. PubMed ID: 33016858
[TBL] [Abstract][Full Text] [Related]
12. Theoretical studies on FGFR isoform selectivity of FGFR1/FGFR4 inhibitors by molecular dynamics simulations and free energy calculations.
Fu W; Chen L; Wang Z; Kang Y; Wu C; Xia Q; Liu Z; Zhou J; Liang G; Cai Y
Phys Chem Chem Phys; 2017 Feb; 19(5):3649-3659. PubMed ID: 28094372
[TBL] [Abstract][Full Text] [Related]
13. Microsecond molecular dynamics simulations provide insight into the ATP-competitive inhibitor-induced allosteric protection of Akt kinase phosphorylation.
Mou L; Cui T; Liu W; Zhang H; Cai Z; Lu S; Gao G
Chem Biol Drug Des; 2017 May; 89(5):723-731. PubMed ID: 27797456
[TBL] [Abstract][Full Text] [Related]
14. Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis.
Dell'Era P; Mohammadi M; Presta M
Mol Biol Cell; 1999 Jan; 10(1):23-33. PubMed ID: 9880324
[TBL] [Abstract][Full Text] [Related]
15. Structural analysis of the mechanism of phosphorylation of a critical autoregulatory tyrosine residue in FGFR1 kinase domain.
Kobashigawa Y; Amano S; Yokogawa M; Kumeta H; Morioka H; Inouye M; Schlessinger J; Inagaki F
Genes Cells; 2015 Oct; 20(10):860-70. PubMed ID: 26300540
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of NEDD4 activates its ubiquitin ligase activity.
Persaud A; Alberts P; Mari S; Tong J; Murchie R; Maspero E; Safi F; Moran MF; Polo S; Rotin D
Sci Signal; 2014 Oct; 7(346):ra95. PubMed ID: 25292214
[TBL] [Abstract][Full Text] [Related]
17. p38γ activation triggers dynamical changes in allosteric docking sites.
Rodriguez Limardo RG; Ferreiro DN; Roitberg AE; Marti MA; Turjanski AG
Biochemistry; 2011 Mar; 50(8):1384-95. PubMed ID: 21235211
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin induces endothelial cell migration through β1 integrin and Src-dependent phosphorylation of fibroblast growth factor receptor-1 at tyrosines 653/654 and 766.
Zou L; Cao S; Kang N; Huebert RC; Shah VH
J Biol Chem; 2012 Mar; 287(10):7190-202. PubMed ID: 22247553
[TBL] [Abstract][Full Text] [Related]
19. Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.
Ling L; Tan SK; Goh TH; Cheung E; Nurcombe V; van Wijnen AJ; Cool SM
Mol Cancer; 2015 Jul; 14():136. PubMed ID: 26201468
[TBL] [Abstract][Full Text] [Related]
20. A novel non-ATP competitive FGFR1 inhibitor with therapeutic potential on gastric cancer through inhibition of cell proliferation, survival and migration.
Wu J; Du X; Li W; Zhou Y; Bai E; Kang Y; Chen Q; Fu W; Yun D; Xu Q; Qiu P; Jin R; Cai Y; Liang G
Apoptosis; 2017 Jun; 22(6):852-864. PubMed ID: 28315172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
